SHELBY PATTERSON: Open Payments
NPI 1710611603 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 30 payments from 13 companies in 2025. Trend: 2023 $434 · 2024 $661 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $174 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $122 |
| Lundbeck LLC | 4 | $76 |
| Lilly USA, LLC | 5 | $74 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| PFIZER INC. | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $32 |
| GlaxoSmithKline, LLC. | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Boston Scientific Corporation | 1 | $17 |
Products named: JOURNAVX, Wegovy, REXULTI, AIRSUPRA, JARDIANCE, Ozempic, FANAPT, TRELEGY ELLIPTA.
Industry payments across IN — which companies pay providers there.
